In summary, RBM20 remains an intriguing target to therapeutically change titin (and thereby cardiac) compliance; however, potential side effects of RBM20 inhibition, including the potential induction of arrhythmias, cannot be neglected. The gene discussed is RBM20; the disease is cardiac arrhythmia.